APO Research
Talk to an analyst

APO RESEARCH · REPORT

Budesonide Capsules

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Budesonide Capsules Industry Growth and Trends Forecast to 2032

20 December 202597 pages

Choose your research edition.

Industry ResearchBudesonide Capsules Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Budesonide Capsules Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Budesonide Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Budesonide Capsules Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Budesonide Capsules Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Budesonide Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Budesonide Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Budesonide Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Budesonide Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Budesonide Capsules include Amneal, Mayne Pharma, Perrigo, Sciecure Pharma, Tillotts Pharma, Zydus Pharmaceuticals, Mylan and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Budesonide Capsules market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Budesonide Capsules market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Budesonide Capsules market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Budesonide Capsules.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Budesonide Capsules market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Budesonide Capsules Market by Company

Amneal

Mayne Pharma

Perrigo

Sciecure Pharma

Tillotts Pharma

Zydus Pharmaceuticals

Mylan

Teva

Budesonide Capsules Segment by Type

1mg

2mg

3mg

Budesonide Capsules Segment by Application

Autoimmune Hepatitis

Crohn's Disease

Collagenous Colitis

Budesonide Capsules Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Budesonide Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Budesonide Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Budesonide Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Budesonide Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Budesonide Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1mg Table 2. Major Company of 2mg Table 3. Major Company of 3mg Table 4. Global Budesonide Capsules Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Budesonide Capsules Sales by Type (2021-2026) & (W Units) Table 6. Global Budesonide Capsules Sales Market Share in Volume by Type (2021-2026) Table 7. Global Budesonide Capsules Sales by Type (2021-2026) & (US$ Million) Table 8. Global Budesonide Capsules Sales Market Share in Value by Type (2021-2026) Table 9. Global Budesonide Capsules Price by Type (2021-2026) & (US$/Unit) Table 10. Global Budesonide Capsules Sales by Type (2027-2032) & (W Units) Table 11. Global Budesonide Capsules Sales Market Share in Volume by Type (2027-2032) Table 12. Global Budesonide Capsules Sales by Type (2027-2032) & (US$ Million) Table 13. Global Budesonide Capsules Sales Market Share in Value by Type (2027-2032) Table 14. Global Budesonide Capsules Price by Type (2027-2032) & (US$/Unit) Table 15. North America Budesonide Capsules Sales by Type (2021-2026) & (W Units) Table 16. North America Budesonide Capsules Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Budesonide Capsules Sales by Type (2021-2026) & (W Units) Table 18. Europe Budesonide Capsules Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Budesonide Capsules Sales by Type (2021-2026) & (W Units) Table 20. Asia-Pacific Budesonide Capsules Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Budesonide Capsules Sales by Type (2021-2026) & (W Units) Table 22. Latin America Budesonide Capsules Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Budesonide Capsules Sales by Type (2021-2026) & (W Units) Table 24. Middle East and Africa Budesonide Capsules Sales by Type (2021-2026) & (US$ Million) Table 25. Budesonide Capsules Industry Trends Table 26. Budesonide Capsules Industry Drivers Table 27. Budesonide Capsules Industry Opportunities and Challenges Table 28. Budesonide Capsules Industry Restraints Table 29. Global Budesonide Capsules Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Budesonide Capsules Revenue Market Share by Company (2021-2026) Table 31. Global Budesonide Capsules Sales by Company (2021-2026) & (W Units) Table 32. Global Budesonide Capsules Sales Share by Company (2021-2026) Table 33. Global Budesonide Capsules Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Budesonide Capsules Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Budesonide Capsules Major Company Production Sites and Headquarters Table 36. Global Budesonide Capsules Company, Product Type & Application Table 37. Global Budesonide Capsules Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Budesonide Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Budesonide Capsules Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Budesonide Capsules Sales by Region (2021-2026) & (W Units) Table 42. Global Budesonide Capsules Sales Market Share in Volume by Region (2021-2026) Table 43. Global Budesonide Capsules Sales by Region (2021-2026) & (US$ Million) Table 44. Global Budesonide Capsules Sales Market Share in Value by Region (2021-2026) Table 45. Global Budesonide Capsules Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Budesonide Capsules Sales by Region (2027-2032) & (W Units) Table 47. Global Budesonide Capsules Sales Market Share in Volume by Region (2027-2032) Table 48. Global Budesonide Capsules Sales by Region (2027-2032) & (US$ Million) Table 49. Global Budesonide Capsules Sales Market Share in Value by Region (2027-2032) Table 50. Global Budesonide Capsules Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Budesonide Capsules Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Budesonide Capsules Sales by Application (2021-2026) & (W Units) Table 53. Global Budesonide Capsules Sales Market Share in Volume by Application (2021-2026) Table 54. Global Budesonide Capsules Sales by Application (2021-2026) & (US$ Million) Table 55. Global Budesonide Capsules Sales Market Share in Value by Application (2021-2026) Table 56. Global Budesonide Capsules Price by Application (2021-2026) & (US$/Unit) Table 57. Global Budesonide Capsules Sales by Application (2027-2032) & (W Units) Table 58. Global Budesonide Capsules Sales Market Share in Volume by Application (2027-2032) Table 59. Global Budesonide Capsules Sales by Application (2027-2032) & (US$ Million) Table 60. Global Budesonide Capsules Sales Market Share in Value by Application (2027-2032) Table 61. Global Budesonide Capsules Price by Application (2027-2032) & (US$/Unit) Table 62. North America Budesonide Capsules Sales by Application (2021-2026) & (W Units) Table 63. North America Budesonide Capsules Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Budesonide Capsules Sales by Application (2021-2026) & (W Units) Table 65. Europe Budesonide Capsules Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Budesonide Capsules Sales by Application (2021-2026) & (W Units) Table 67. Asia-Pacific Budesonide Capsules Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Budesonide Capsules Sales by Application (2021-2026) & (W Units) Table 69. Latin America Budesonide Capsules Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Budesonide Capsules Sales by Application (2021-2026) & (W Units) Table 71. Middle East and Africa Budesonide Capsules Sales by Application (2021-2026) & (US$ Million) Table 72. Amneal Company Information Table 73. Amneal Business Overview Table 74. Amneal Budesonide Capsules Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Amneal Budesonide Capsules Product Portfolio Table 76. Amneal Recent Development Table 77. Mayne Pharma Company Information Table 78. Mayne Pharma Business Overview Table 79. Mayne Pharma Budesonide Capsules Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Mayne Pharma Budesonide Capsules Product Portfolio Table 81. Mayne Pharma Recent Development Table 82. Perrigo Company Information Table 83. Perrigo Business Overview Table 84. Perrigo Budesonide Capsules Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Perrigo Budesonide Capsules Product Portfolio Table 86. Perrigo Recent Development Table 87. Sciecure Pharma Company Information Table 88. Sciecure Pharma Business Overview Table 89. Sciecure Pharma Budesonide Capsules Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Sciecure Pharma Budesonide Capsules Product Portfolio Table 91. Sciecure Pharma Recent Development Table 92. Tillotts Pharma Company Information Table 93. Tillotts Pharma Business Overview Table 94. Tillotts Pharma Budesonide Capsules Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Tillotts Pharma Budesonide Capsules Product Portfolio Table 96. Tillotts Pharma Recent Development Table 97. Zydus Pharmaceuticals Company Information Table 98. Zydus Pharmaceuticals Business Overview Table 99. Zydus Pharmaceuticals Budesonide Capsules Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Zydus Pharmaceuticals Budesonide Capsules Product Portfolio Table 101. Zydus Pharmaceuticals Recent Development Table 102. Mylan Company Information Table 103. Mylan Business Overview Table 104. Mylan Budesonide Capsules Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Mylan Budesonide Capsules Product Portfolio Table 106. Mylan Recent Development Table 107. Teva Company Information Table 108. Teva Business Overview Table 109. Teva Budesonide Capsules Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Teva Budesonide Capsules Product Portfolio Table 111. Teva Recent Development Table 112. North America Budesonide Capsules Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 113. North America Budesonide Capsules Sales by Country (2021-2026) & (W Units) Table 114. North America Budesonide Capsules Sales Market Share by Country (2021-2026) Table 115. North America Budesonide Capsules Sales Forecast by Country (2027-2032) & (W Units) Table 116. North America Budesonide Capsules Sales Market Share Forecast by Country (2027-2032) Table 117. North America Budesonide Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Budesonide Capsules Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Budesonide Capsules Market Share by Country (2021-2026) Table 120. North America Budesonide Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Budesonide Capsules Market Share Forecast by Country (2027-2032) Table 122. Europe Budesonide Capsules Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 123. Europe Budesonide Capsules Sales by Country (2021-2026) & (W Units) Table 124. Europe Budesonide Capsules Sales Market Share by Country (2021-2026) Table 125. Europe Budesonide Capsules Sales Forecast by Country (2027-2032) & (W Units) Table 126. Europe Budesonide Capsules Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Budesonide Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Budesonide Capsules Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Budesonide Capsules Market Share by Country (2021-2026) Table 130. Europe Budesonide Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Budesonide Capsules Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Budesonide Capsules Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Budesonide Capsules Sales by Country (2021-2026) & (W Units) Table 134. Asia-Pacific Budesonide Capsules Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Budesonide Capsules Sales Forecast by Country (2027-2032) & (W Units) Table 136. Asia-Pacific Budesonide Capsules Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Budesonide Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Budesonide Capsules Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Budesonide Capsules Market Share by Country (2021-2026) Table 140. Asia-Pacific Budesonide Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Budesonide Capsules Market Share Forecast by Country (2027-2032) Table 142. Latin America Budesonide Capsules Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 143. Latin America Budesonide Capsules Sales by Country (2021-2026) & (W Units) Table 144. Latin America Budesonide Capsules Sales Market Share by Country (2021-2026) Table 145. Latin America Budesonide Capsules Sales Forecast by Country (2027-2032) & (W Units) Table 146. Latin America Budesonide Capsules Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Budesonide Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Budesonide Capsules Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Budesonide Capsules Market Share by Country (2021-2026) Table 150. Latin America Budesonide Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Budesonide Capsules Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Budesonide Capsules Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Budesonide Capsules Sales by Country (2021-2026) & (W Units) Table 154. Middle East and Africa Budesonide Capsules Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Budesonide Capsules Sales Forecast by Country (2027-2032) & (W Units) Table 156. Middle East and Africa Budesonide Capsules Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Budesonide Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Budesonide Capsules Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Budesonide Capsules Market Share by Country (2021-2026) Table 160. Middle East and Africa Budesonide Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Budesonide Capsules Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Budesonide Capsules Distributors List Table 165. Budesonide Capsules Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Budesonide Capsules Image Figure 2. Global Budesonide Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Budesonide Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Budesonide Capsules Sales (2021-2032) & (W Units) Figure 5. 1mg Image Figure 6. Global 1mg Sales YoY Growth (2021-2032) & (W Units) Figure 7. 2mg Image Figure 8. Global 2mg Sales YoY Growth (2021-2032) & (W Units) Figure 9. 3mg Image Figure 10. Global 3mg Sales YoY Growth (2021-2032) & (W Units) Figure 11. Global Budesonide Capsules Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Budesonide Capsules Market Share by Type 2025 VS 2032 Figure 13. North America Budesonide Capsules Sales Market Share in Volume by Type in 2025 Figure 14. North America Budesonide Capsules Sales Market Share in Value by Type in 2025 Figure 15. Europe Budesonide Capsules Sales Market Share in Volume by Type in 2025 Figure 16. Europe Budesonide Capsules Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Budesonide Capsules Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Budesonide Capsules Sales Market Share in Value by Type in 2025 Figure 19. Latin America Budesonide Capsules Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Budesonide Capsules Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Budesonide Capsules Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Budesonide Capsules Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Budesonide Capsules Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Autoimmune Hepatitis Image Figure 26. Global Autoimmune Hepatitis Sales YoY Growth (2021-2032) & (W Units) Figure 27. Crohn's Disease Image Figure 28. Global Crohn's Disease Sales YoY Growth (2021-2032) & (W Units) Figure 29. Collagenous Colitis Image Figure 30. Global Collagenous Colitis Sales YoY Growth (2021-2032) & (W Units) Figure 31. Global Budesonide Capsules Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Budesonide Capsules Market Share by Application 2025 VS 2032 Figure 33. North America Budesonide Capsules Sales Market Share in Volume by Application in 2025 Figure 34. North America Budesonide Capsules Sales Market Share in Value by Application in 2025 Figure 35. Europe Budesonide Capsules Sales Market Share in Volume by Application in 2025 Figure 36. Europe Budesonide Capsules Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Budesonide Capsules Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Budesonide Capsules Sales Market Share in Value by Application in 2025 Figure 39. Latin America Budesonide Capsules Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Budesonide Capsules Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Budesonide Capsules Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Budesonide Capsules Sales Market Share in Value by Application in 2025 Figure 43. North America Budesonide Capsules Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. North America Budesonide Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Budesonide Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Budesonide Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Budesonide Capsules Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Europe Budesonide Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Budesonide Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Budesonide Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Budesonide Capsules Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Asia-Pacific Budesonide Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Budesonide Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Budesonide Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Budesonide Capsules Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Latin America Budesonide Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Budesonide Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Budesonide Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Budesonide Capsules Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Middle East and Africa Budesonide Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Budesonide Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Budesonide Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Budesonide Capsules Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Budesonide Capsules Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 1mg
  • 2mg
  • 3mg
Applications
  • Autoimmune Hepatitis
  • Crohn's Disease
  • Collagenous Colitis
Companies covered
  • Amneal
  • Mayne Pharma
  • Perrigo
  • Sciecure Pharma
  • Tillotts Pharma
  • Zydus Pharmaceuticals
  • Mylan
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Budesonide Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Budesonide Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Budesonide Capsules Market by Type
  6. 1.3.1 1mg
  7. 1.3.2 2mg
  8. 1.3.3 3mg
  9. 1.4 Global Budesonide Capsules Market Size by Type
  10. 1.4.1 Global Budesonide Capsules Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Budesonide Capsules Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Budesonide Capsules Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Budesonide Capsules Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Budesonide Capsules Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Budesonide Capsules Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Budesonide Capsules Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Budesonide Capsules Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Budesonide Capsules Industry Trends
  2. 2.2 Budesonide Capsules Industry Drivers
  3. 2.3 Budesonide Capsules Industry Opportunities and Challenges
  4. 2.4 Budesonide Capsules Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Budesonide Capsules Revenue (2021-2026)
  2. 3.2 Global Top Players by Budesonide Capsules Sales (2021-2026)
  3. 3.3 Global Top Players by Budesonide Capsules Price (2021-2026)
  4. 3.4 Global Budesonide Capsules Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Budesonide Capsules Major Company Production Sites & Headquarters
  6. 3.6 Global Budesonide Capsules Company, Product Type & Application
  7. 3.7 Global Budesonide Capsules Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Budesonide Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Budesonide Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Budesonide Capsules Tier 1, Tier 2, and Tier 3
4 Budesonide Capsules Regional Status and Outlook
  1. 4.1 Global Budesonide Capsules Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Budesonide Capsules Historic Market Size by Region
  3. 4.2.1 Global Budesonide Capsules Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Budesonide Capsules Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Budesonide Capsules Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Budesonide Capsules Forecasted Market Size by Region
  7. 4.3.1 Global Budesonide Capsules Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Budesonide Capsules Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Budesonide Capsules Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Budesonide Capsules by Application
  1. 5.1 Budesonide Capsules Market by Application
  2. 5.1.1 Autoimmune Hepatitis
  3. 5.1.2 Crohn's Disease
  4. 5.1.3 Collagenous Colitis
  5. 5.2 Global Budesonide Capsules Market Size by Application
  6. 5.2.1 Global Budesonide Capsules Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Budesonide Capsules Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Budesonide Capsules Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Budesonide Capsules Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Budesonide Capsules Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Budesonide Capsules Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Budesonide Capsules Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Budesonide Capsules Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Amneal
  2. 6.1.1 Amneal Company Information
  3. 6.1.2 Amneal Business Overview
  4. 6.1.3 Amneal Budesonide Capsules Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Amneal Budesonide Capsules Product Portfolio
  6. 6.1.5 Amneal Recent Developments
  7. 6.2 Mayne Pharma
  8. 6.2.1 Mayne Pharma Company Information
  9. 6.2.2 Mayne Pharma Business Overview
  10. 6.2.3 Mayne Pharma Budesonide Capsules Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mayne Pharma Budesonide Capsules Product Portfolio
  12. 6.2.5 Mayne Pharma Recent Developments
  13. 6.3 Perrigo
  14. 6.3.1 Perrigo Company Information
  15. 6.3.2 Perrigo Business Overview
  16. 6.3.3 Perrigo Budesonide Capsules Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Perrigo Budesonide Capsules Product Portfolio
  18. 6.3.5 Perrigo Recent Developments
  19. 6.4 Sciecure Pharma
  20. 6.4.1 Sciecure Pharma Company Information
  21. 6.4.2 Sciecure Pharma Business Overview
  22. 6.4.3 Sciecure Pharma Budesonide Capsules Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sciecure Pharma Budesonide Capsules Product Portfolio
  24. 6.4.5 Sciecure Pharma Recent Developments
  25. 6.5 Tillotts Pharma
  26. 6.5.1 Tillotts Pharma Company Information
  27. 6.5.2 Tillotts Pharma Business Overview
  28. 6.5.3 Tillotts Pharma Budesonide Capsules Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Tillotts Pharma Budesonide Capsules Product Portfolio
  30. 6.5.5 Tillotts Pharma Recent Developments
  31. 6.6 Zydus Pharmaceuticals
  32. 6.6.1 Zydus Pharmaceuticals Company Information
  33. 6.6.2 Zydus Pharmaceuticals Business Overview
  34. 6.6.3 Zydus Pharmaceuticals Budesonide Capsules Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Zydus Pharmaceuticals Budesonide Capsules Product Portfolio
  36. 6.6.5 Zydus Pharmaceuticals Recent Developments
  37. 6.7 Mylan
  38. 6.7.1 Mylan Company Information
  39. 6.7.2 Mylan Business Overview
  40. 6.7.3 Mylan Budesonide Capsules Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Mylan Budesonide Capsules Product Portfolio
  42. 6.7.5 Mylan Recent Developments
  43. 6.8 Teva
  44. 6.8.1 Teva Company Information
  45. 6.8.2 Teva Business Overview
  46. 6.8.3 Teva Budesonide Capsules Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Teva Budesonide Capsules Product Portfolio
  48. 6.8.5 Teva Recent Developments
7 North America by Country
  1. 7.1 North America Budesonide Capsules Sales by Country
  2. 7.1.1 North America Budesonide Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Budesonide Capsules Sales by Country (2021-2026)
  4. 7.1.3 North America Budesonide Capsules Sales Forecast by Country (2027-2032)
  5. 7.2 North America Budesonide Capsules Market Size by Country
  6. 7.2.1 North America Budesonide Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Budesonide Capsules Market Size by Country (2021-2026)
  8. 7.2.3 North America Budesonide Capsules Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Budesonide Capsules Sales by Country
  2. 8.1.1 Europe Budesonide Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Budesonide Capsules Sales by Country (2021-2026)
  4. 8.1.3 Europe Budesonide Capsules Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Budesonide Capsules Market Size by Country
  6. 8.2.1 Europe Budesonide Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Budesonide Capsules Market Size by Country (2021-2026)
  8. 8.2.3 Europe Budesonide Capsules Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Budesonide Capsules Sales by Country
  2. 9.1.1 Asia-Pacific Budesonide Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Budesonide Capsules Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Budesonide Capsules Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Budesonide Capsules Market Size by Country
  6. 9.2.1 Asia-Pacific Budesonide Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Budesonide Capsules Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Budesonide Capsules Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Budesonide Capsules Sales by Country
  2. 10.1.1 South America Budesonide Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Budesonide Capsules Sales by Country (2021-2026)
  4. 10.1.3 South America Budesonide Capsules Sales Forecast by Country (2027-2032)
  5. 10.2 South America Budesonide Capsules Market Size by Country
  6. 10.2.1 South America Budesonide Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Budesonide Capsules Market Size by Country (2021-2026)
  8. 10.2.3 South America Budesonide Capsules Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Budesonide Capsules Sales by Country
  2. 11.1.1 Middle East and Africa Budesonide Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Budesonide Capsules Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Budesonide Capsules Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Budesonide Capsules Market Size by Country
  6. 11.2.1 Middle East and Africa Budesonide Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Budesonide Capsules Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Budesonide Capsules Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Budesonide Capsules Value Chain Analysis
  2. 12.1.1 Budesonide Capsules Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Budesonide Capsules Production Mode & Process
  7. 12.2 Budesonide Capsules Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Budesonide Capsules Distributors
  10. 12.2.3 Budesonide Capsules Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst